-+ 0.00%
-+ 0.00%
-+ 0.00%

TELIX PHARMACEUTICALS - INITIATION OF PART 2 IN U.S. SUBJECT TO FDA IND AMENDMENT REVIEW

Reuters·07/02/2026 00:07:32

Please log in to view news